TEX10: A Novel Drug Target and Potential Therapeutic Direction for Sleep Apnea Syndrome
Our study identified multiple potential therapeutic targets causally linked to SAS, with TEX10 emerging as a key candidate gene. These findings advance our understanding of SAS pathogenesis and offer promising directions for personalized diagnostics and targeted therapies.
Authors
- Hui Su
- Sufang Shi (ORCID: https://orcid.org/0000-0002-8949-7054)
- Zhitao Fan (ORCID: https://orcid.org/0000-0002-8258-1069)
- Anqi Zhang (ORCID: https://orcid.org/0000-0001-5128-2464)
- Pengfei Shi (ORCID: https://orcid.org/0000-0002-9657-1478)
- Tong Qiao (ORCID: https://orcid.org/0009-0003-6665-8630)
Institutions
- Hebei Medical University (CN)
- Xingtai People's Hospital (CN)
- Hebei Eye Hospital (CN)
Publication Details
- Journal
- Nature and Science of Sleep
- Published
- 2025-05-01
- DOI
- https://doi.org/10.2147/nss.s499895
- Citations
- 1
- Primary Topic
- Genetics and Neurodevelopmental Disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.82